Bill Text: CT SB00435 | 2017 | General Assembly | Introduced
Bill Title: An Act Providing Access To Prescription Brands That Are Medically Necessary For People Diagnosed With Epilepsy.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2017-01-19 - Referred to Joint Committee on Public Health [SB00435 Detail]
Download: Connecticut-2017-SB00435-Introduced.html
General Assembly |
Proposed Bill No. 435 |
||||
January Session, 2017 |
LCO No. 3113 | ||||
*03113* | |||||
Referred to Committee on PUBLIC HEALTH |
|||||
Introduced by: |
|||||
SEN. SLOSSBERG, 14th Dist. |
|||||
AN ACT PROVIDING ACCESS TO PRESCRIPTION BRANDS THAT ARE MEDICALLY NECESSARY FOR PEOPLE DIAGNOSED WITH EPILEPSY.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
That the general statutes be amended to provide access to prescription brands that are medically necessary for the treatment of persons diagnosed with epilepsy.
Statement of Purpose:
To provide access to prescription drug brands that are medically necessary for the treatment of persons diagnosed with epilepsy.